Pan-EU RWD Network To Support EMA Evaluations Draws Nearer
First DARWIN EU Pilot Studies To Be Delivered In 2022
Efforts to set up an EU-wide network of real-world data sources to support medicines evaluation are gathering pace.
You may also be interested in...
An EU-wide network of real-world data sources will aim to become the dominant vehicle for delivering such evidence to the EMA and member countries, who have until now been using a wide range of different sources to access such data.
A panel of regulators overseeing the implementation of several big data projects within the EU medicines network has given details of real-world evidence integration pilots to be undertaken next year by various European Medicines Agency scientific committees.
The European Medicines Agency is inviting feedback from organizations interested in setting up and operating an EU-wide database network and healthcare data analysis platform.